GlaxoSmithKline Appoint Creative Lynx

After a competitive 4 way pitch in December 2008, Creative Lynx were appointed to re-vitalise a key division of GlaxoSmithKline UK. Following months of insight research and creative development we are continuing to work closely with GSK to revitalise the brand in the hearts and minds of both internal and external stakeholders, maximising emerging technologies. David Whittingham, Healthcare Director at Creative Lynx, comments that, “The response to our work with GSK has been incredibly rewarding and I believe it is a further example of how our market understanding coupled with our design pedigree and digital innovation can get results and lead to fruitful partnerships.